Ingrid Abrahamsen is an experienced clinical research leader with a focus on clinical trial management and clinical operations. Her 15 years of experience have been concentrated in early and late phase rare disease and oncology clinical research. Her experience in the span of the last 5 years has been focused in the cell and gene therapy (CGT) industry, contributing to the clinical development of multiple autologous cell and gene therapies. Most recently, Ingrid was leading clinical operations at Editas Medicine in the development of reni-cel, an AsCas12a gene-edited cell therapy in severe sickle cell disease (SCD).
In her Clinical Operations leadership roles, Ingrid has formed and led teams to optimize clinical trial execution and build cross-functional relationships. Ingrid is currently the Head of Clinical Operations at Fulcrum Therapeutics, leading the advancement of their small molecule pipeline with their lead clinical program in SCD. Ingrid holds an MS and BS from Penn State University and is a Certified Clinical Research Professional (CCRP) via the Society of Clinical Research Associates (SOCRA).
Kento Nakamura is a global professional having worked both in the Western and Eastern healthcare landscapes. He has been in various roles, contributing significantly to drug development, market access, and pharmaceutical marketing.
At CMIC, Japan and South Korea’s first CRO, Kento wears multiple hats including helping formulate corporate strategy, creating mutually beneficial partnerships with other companies, and taking initiative to create business development opportunities.
During his tenure at KM Pharmaceutical Consulting, a boutique drug development consulting firm, Kento co-pioneered the market access perspective on drug development, resulting in key additional endpoints in an ongoing phase 2 study. He also played a crucial role in developing the global drug safety plan, ensuring compliance with reporting requirements across multiple continents.
Kento holds an MPH in Health Management from Harvard University and a BS in Biology from Tufts University. He is fluent in English and Japanese. In his free time, Kento enjoys playing tennis, watching football, visiting contemporary art museums, and traveling around the world.
